Search

  • HOME
  • Search
Review
1770
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.   Published online February 1, 2023
View: 6497   Download: 425  Web of Science: 24  Crossref: 30
Original Article
1712
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):841-850.   Published online September 19, 2022
View: 8841   Download: 271  Web of Science: 100  Crossref: 107
Review
1668
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Clin Mol Hepatol. 2022;28(4):725-738.   Published online March 14, 2022
View: 5576   Download: 259  Web of Science: 12  Crossref: 15
Editorial
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Byoung Seok Ye
Clin Mol Hepatol. 2022;28(3):481-482.   Published online May 16, 2022
View: 3189   Download: 81  Web of Science: 1  Crossref: 2
Letter to the Editor
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online February 15, 2022
View: 5750   Download: 375  Web of Science: 11  Crossref: 10
Original Article
1656
Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
Clin Mol Hepatol. 2022;28(2):196-206.   Published online January 13, 2022
View: 6359   Download: 217  Web of Science: 17  Crossref: 17
1603
Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo
Clin Mol Hepatol. 2021;27(3):463-473.   Published online February 15, 2021
View: 6098   Download: 172  Web of Science: 3  Crossref: 4
Review
1612
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee, On behalf of Korean NAFLD Study Group
Clin Mol Hepatol. 2021;27(2):257-269.   Published online March 22, 2021
View: 9480   Download: 441  Web of Science: 66  Crossref: 66
Editorial
1590
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol. 2021;27(1):87-90.   Published online December 3, 2020
View: 5323   Download: 116  Web of Science: 13  Crossref: 16
1588
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 5318   Download: 165  Web of Science: 1  Crossref: 1
Review
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 10637   Download: 494  Web of Science: 43  Crossref: 46
1486
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2020;26(2):128-141.   Published online November 8, 2019
View: 15519   Download: 573  Web of Science: 69  Crossref: 74
Original Article
1430
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol. 2019;25(1):52-64.   Published online October 23, 2018
View: 9175   Download: 353  Web of Science: 78  Crossref: 77
The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani
Clin Mol Hepatol. 2016;22(1):146-151.   Published online March 28, 2016
View: 10628   Download: 144  Web of Science: 47  Crossref: 46
1166
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
Clin Mol Hepatol. 2015;21(4):379-386.   Published online December 24, 2015
View: 12626   Download: 175  Web of Science: 15  Crossref: 12
Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
Hyo Jeong Oh, Tae Hyeon Kim, Young Woo Sohn, Yong Sung Kim, Yong Reol Oh, Eun Young Cho, So Yeon Shim, Sae Ron Shin, A Lum Han, Seok Jin Yoon, Haak Cheoul Kim
Clin Mol Hepatol. 2011;17(1):27-36.   Published online March 21, 2011
View: 10335   Download: 86  Crossref: 52
Editorial
Liver function tests as indicators of metabolic syndrome
Han Chu Lee
Clin Mol Hepatol. 2011;17(1):9-11.   Published online March 21, 2011
View: 5807   Download: 49  Crossref: 4
1
Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease
Hyun Seok Jin , Berm Seok Oh
Clin Mol Hepatol. 2009;15(3):295-298.   Published online September 30, 2009
View: 4377   Download: 42
3
Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty Liver disease to carotid atherosclerosis
Su-Yeon Choi, M.D., Donghee Kim, M.D., Jin Hwa Kang, M.D. Min Jung Park, M.D., Young Sun Kim, M.D., Seon Hee Lim, M.D., Chung Hyeon Kim, M.D., Hyo-Suk Lee, M.D.
Clin Mol Hepatol. 2008;14(1):77-88.   Published online March 20, 2008
View: 6884   Download: 130  Crossref: 30
1
Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease
Moon Young Kim , Soon Koo Baik
Clin Mol Hepatol. 2008;14(1):1-3.   Published online March 20, 2008
View: 5104   Download: 65  Crossref: 2
5
Nonalcoholic Steatohepatitis
So-Young Jin
Clin Mol Hepatol. 2006;12(3):455-459.   Published online January 1, 2000
View: 2703   Download: 21
3
The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease
Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.
Clin Mol Hepatol. 2004;10(3):197-206.   Published online January 1, 1970
View: 3270   Download: 59
The Short Term Prognosis in Alcoholic Liver Disease with Metabolic Acidosis
Ki Sun Bae , Kwon Yoo , You Kyung Cho , Ki Nam Shim , Sung Ae Jung , Il Hwan Moon
Clin Mol Hepatol. 2004;10(2):117-124.   Published online January 1, 1970
View: 2832   Download: 31
Review
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Received April 10, 2024  Accepted June 26, 2024  
View: 2010   Download: 136  Crossref: 1
Correspondence
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD
Baokai Sun, Likun Zhuang
Received September 3, 2024  Accepted September 7, 2024  
View: 307   Download: 51
Review
Roles of X-box binding protein 1 in liver pathogenesis
Jihoon Tak, Yun Seok Kim, Sang Geon Kim
Received June 10, 2024  Accepted September 27, 2024  
View: 520   Download: 60
Editorial
Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease
Won Sohn
Received September 21, 2024  Accepted October 9, 2024  
View: 253   Download: 14
Original Article
Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments
Carlos Jose Pirola, Maria Silvina Landa, Mariano Schuman, Silvia Inés García, Adrian Salatino, Silvia Sookoian
Received May 15, 2024  Accepted October 10, 2024  
View: 481   Download: 71
Correspondence
Correspondence on Editorial regarding “Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease”
Young Eun Chon, Jung Hwan Yu, Seung Up Kim
Received October 6, 2024  Accepted October 11, 2024  
View: 220   Download: 11
1 | 2 | 3 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 979
TOTAL : 2178430
Close layer